Vincenzo Nigro Selected Research

Drug Resistant Epilepsy

1/2020

Loss of Wwox Perturbs Neuronal Migration and Impairs Early Cortical Development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincenzo Nigro Research Topics

Disease

17	Muscular Diseases (Myopathy) 12/2023 - 07/2008
17	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 12/2023 - 11/2003
16	Muscular Dystrophies (Muscular Dystrophy) 01/2023 - 05/2002
6	Cardiomyopathies (Cardiomyopathy) 01/2023 - 01/2009
6	Neurodevelopmental Disorders 01/2023 - 01/2019
5	Disease Progression 01/2022 - 12/2002
4	Distal Myopathies (Distal Muscular Dystrophy) 12/2023 - 02/2011
4	Type 1C Limb-Girdle Muscular Dystrophy 08/2014 - 12/2003
3	Epilepsy (Aura) 12/2023 - 01/2020
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2023 - 11/2015
3	Microcephaly 01/2023 - 01/2022
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 12/2018
3	Intellectual Disability (Idiocy) 01/2023 - 01/2022
3	Sarcoglycanopathies 01/2020 - 05/2014
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 10/2011
3	Type 1F Limb-Girdle Muscular Dystrophy 08/2014 - 01/2013
3	Type 2I Limb-Girdle Muscular Dystrophy 05/2014 - 12/2003
3	type 2B Limb-girdle muscular dystrophy 05/2014 - 02/2011
2	Brain Diseases (Brain Disorder) 04/2024 - 11/2021
2	Glycogen Storage Disease (Glycogenosis) 01/2024 - 10/2015
2	Atrophy 12/2023 - 08/2013
2	Thalassemia 01/2023 - 01/2023
2	Cataract (Cataracts) 01/2023 - 10/2017
2	Rare Diseases (Rare Disease) 01/2023 - 01/2023
2	Heart Failure 12/2022 - 01/2022
2	Central Core Myopathy (Central Core Disease) 01/2022 - 05/2003
2	Neoplasms (Cancer) 01/2020 - 04/2019
2	Walker-Warburg Syndrome 01/2018 - 05/2014
2	Fibrosis (Cirrhosis) 04/2015 - 01/2009
2	Type 1E Limb-Girdle Muscular Dystrophy 08/2014 - 05/2014
2	type 1B Limb-girdle muscular dystrophy 08/2014 - 05/2014
2	Type 1D Limb-Girdle Muscular Dystrophy 08/2014 - 05/2014
2	Type 1G Limb-Girdle Muscular Dystrophy 08/2014 - 05/2014
2	Limb-girdle muscular dystrophy type 2A 05/2014 - 02/2005
2	Miyoshi myopathy 09/2011 - 02/2011
1	Myocardial Infarction 04/2024
1	Paralysis (Palsy) 04/2024
1	Glycogen Storage Disease Type Ix 01/2024
1	Myalgia 01/2024
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 12/2023
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 12/2023
1	Ataxia (Dyssynergia) 12/2023
1	Spheroid body myopathy 12/2023
1	alpha-Thalassemia 01/2023
1	Angelman Syndrome (Syndrome, Angelman) 01/2023
1	Familial Hypoadrenocorticism 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2022

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2003
11	DystrophinIBA 01/2023 - 05/2002
9	Sarcoglycans (beta Sarcoglycan)IBA 01/2016 - 11/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2011
5	DysferlinIBA 05/2014 - 02/2011
4	Retinaldehyde (Retinal)IBA 12/2022 - 02/2008
4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 05/2003
4	Lamin Type A (Lamin A)IBA 12/2015 - 01/2014
3	DesminIBA 12/2022 - 05/2014
3	SteroidsIBA 01/2020 - 01/2011
3	ConnectinIBA 01/2020 - 05/2014
3	CalpainIBA 05/2014 - 12/2002
3	Caveolin 3IBA 05/2014 - 12/2003
2	Transaminases (Aminotransferases)IBA 01/2024 - 08/2022
2	EnzymesIBA 12/2023 - 10/2015
2	Neurofibromin 1 (Neurofibromin)IBA 02/2023 - 11/2015
2	Protein Isoforms (Isoforms)IBA 01/2023 - 10/2016
2	Muscle Proteins (Muscle Protein)IBA 01/2021 - 03/2010
2	Dystroglycans (Dystroglycan)IBA 01/2018 - 05/2014
2	polyglucosanIBA 10/2015 - 04/2015
2	Karyopherins (Importin)IBA 05/2014 - 01/2013
2	Glycoproteins (Glycoprotein)IBA 11/2011 - 07/2008
1	PotassiumIBA 04/2024
1	MagnesiumIBA 04/2024
1	Acetazolamide (Diamox)FDA LinkGeneric 04/2024
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 04/2024
1	Myosins (Myosin)IBA 02/2024
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2024
1	Heparitin Sulfate (Heparan Sulfate)IBA 12/2023
1	N-sulfoglucosamine sulfohydrolase (sulfamidase)IBA 12/2023
1	Mitogen-Activated Protein KinasesIBA 12/2023
1	Amino Acids FDA Link 12/2023
1	alpha-GlobinsIBA 01/2023
1	GlobinsIBA 01/2023
1	4-chlorophenyl methyl sulfide (CPMS)IBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	phosphatidylinositol 4-phosphateIBA 01/2023
1	HyperglycerolemiaIBA 01/2023
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 01/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	Ligases (Synthetase)IBA 01/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2023
1	GTP Phosphohydrolases (GTPases)IBA 01/2023
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2023
1	ElementsIBA 01/2023
1	UbiquitinIBA 01/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 11/2022

Therapy/Procedure

5	Therapeutics 07/2022 - 03/2010
2	Defibrillators (Defibrillator) 04/2024 - 03/2010
2	Ligation 01/2023 - 01/2016